| UniProt ID | NF2L2_HUMAN | |
|---|---|---|
| UniProt AC | Q16236 | |
| Protein Name | Nuclear factor erythroid 2-related factor 2 | |
| Gene Name | NFE2L2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 605 | |
| Subcellular Localization | Cytoplasm, cytosol. Nucleus. Cytosolic under unstressed conditions, translocates into the nucleus upon induction by electrophilic agents. | |
| Protein Description | Transcription activator that binds to antioxidant response (ARE) elements in the promoter regions of target genes. Important for the coordinated up-regulation of genes in response to oxidative stress. May be involved in the transcriptional activation of genes of the beta-globin cluster by mediating enhancer activity of hypersensitive site 2 of the beta-globin locus control region.. | |
| Protein Sequence | MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 28 (in isoform 2) | Ubiquitination | - | 3.40 | 21906983 | |
| 28 | Ubiquitination | DILWRQDIDLGVSRE HHHHHCCCCCCCCHH | 3.40 | 27667366 | |
| 37 | Ubiquitination | LGVSREVFDFSQRRK CCCCHHHHCHHHHHH | 7.22 | 24816145 | |
| 40 | Phosphorylation | SREVFDFSQRRKEYE CHHHHCHHHHHHHHH | 25.31 | 22558124 | |
| 44 | Ubiquitination | FDFSQRRKEYELEKQ HCHHHHHHHHHHHHH | 67.83 | 21906983 | |
| 44 (in isoform 1) | Ubiquitination | - | 67.83 | 21906983 | |
| 48 (in isoform 2) | Ubiquitination | - | 11.03 | 21906983 | |
| 48 | Ubiquitination | QRRKEYELEKQKKLE HHHHHHHHHHHHHHH | 11.03 | 27667366 | |
| 53 | Ubiquitination | YELEKQKKLEKERQE HHHHHHHHHHHHHHH | 60.42 | 24816145 | |
| 64 | Ubiquitination | ERQEQLQKEQEKAFF HHHHHHHHHHHHHHH | 70.70 | 27667366 | |
| 64 (in isoform 1) | Ubiquitination | - | 70.70 | 21906983 | |
| 210 | Phosphorylation | ENDKLVETTMVPSPE CCCEEEEEEEECCCC | 16.83 | 30266825 | |
| 211 | Phosphorylation | NDKLVETTMVPSPEA CCEEEEEEEECCCCC | 11.58 | 30266825 | |
| 215 | Phosphorylation | VETTMVPSPEAKLTE EEEEEECCCCCCCEE | 24.78 | 30266825 | |
| 229 | Phosphorylation | EVDNYHFYSSIPSME EEECCEECCCCCHHH | 6.54 | 27642862 | |
| 243 | Phosphorylation | EKEVGNCSPHFLNAF HCHHHCCCHHHHHHH | 25.96 | 26074081 | |
| 301 | Phosphorylation | SISNSMPSPATLSHS CCCCCCCCCHHHHHH | 20.65 | - | |
| 344 | Phosphorylation | AEFNDSDSGISLNTS CCCCCCCCCCCCCCC | 41.81 | 22751928 | |
| 347 | Phosphorylation | NDSDSGISLNTSPSV CCCCCCCCCCCCCCC | 21.06 | 22751928 | |
| 351 | Phosphorylation | SGISLNTSPSVASPE CCCCCCCCCCCCCCC | 17.69 | 22751928 | |
| 356 | Phosphorylation | NTSPSVASPEHSVES CCCCCCCCCCCCCCC | 28.76 | 22751928 | |
| 374 | Phosphorylation | GDTLLGLSDSEVEEL CCEEECCCHHHHHHH | 36.97 | - | |
| 395 | Phosphorylation | VKQNGPKTPVHSSGD CCCCCCCCCCCCCCC | 33.41 | 29449344 | |
| 399 | Phosphorylation | GPKTPVHSSGDMVQP CCCCCCCCCCCCCCC | 35.93 | 29449344 | |
| 400 | Phosphorylation | PKTPVHSSGDMVQPL CCCCCCCCCCCCCCC | 24.76 | 29449344 | |
| 408 | Phosphorylation | GDMVQPLSPSQGQST CCCCCCCCCCCCCCC | 29.23 | 25159151 | |
| 410 | Phosphorylation | MVQPLSPSQGQSTHV CCCCCCCCCCCCCCC | 43.50 | 29449344 | |
| 414 | Phosphorylation | LSPSQGQSTHVHDAQ CCCCCCCCCCCCCCC | 27.57 | 29449344 | |
| 415 | Phosphorylation | SPSQGQSTHVHDAQC CCCCCCCCCCCCCCC | 21.74 | 29449344 | |
| 425 | Phosphorylation | HDAQCENTPEKELPV CCCCCCCCCCCCCCC | 15.55 | 29449344 | |
| 432 | Ubiquitination | TPEKELPVSPGHRKT CCCCCCCCCCCCCCC | 19.73 | 29967540 | |
| 433 | Phosphorylation | PEKELPVSPGHRKTP CCCCCCCCCCCCCCC | 24.19 | 30266825 | |
| 437 | Methylation | LPVSPGHRKTPFTKD CCCCCCCCCCCCCCC | 50.92 | 112847407 | |
| 438 | Acetylation | PVSPGHRKTPFTKDK CCCCCCCCCCCCCCC | 55.67 | 19273602 | |
| 439 | Ubiquitination | VSPGHRKTPFTKDKH CCCCCCCCCCCCCCC | 24.48 | 29967540 | |
| 439 | Phosphorylation | VSPGHRKTPFTKDKH CCCCCCCCCCCCCCC | 24.48 | - | |
| 443 | Acetylation | HRKTPFTKDKHSSRL CCCCCCCCCCCCHHH | 66.22 | 19273602 | |
| 445 | Acetylation | KTPFTKDKHSSRLEA CCCCCCCCCCHHHHH | 47.12 | 19273602 | |
| 446 | Ubiquitination | TPFTKDKHSSRLEAH CCCCCCCCCHHHHHH | 40.93 | 29967540 | |
| 447 | Phosphorylation | PFTKDKHSSRLEAHL CCCCCCCCHHHHHHH | 23.93 | - | |
| 462 | N-linked_Glycosylation | TRDELRAKALHIPFP CHHHHHHHHHCCCCC | 45.08 | 31398338 | |
| 462 | Acetylation | TRDELRAKALHIPFP CHHHHHHHHHCCCCC | 45.08 | 19273602 | |
| 462 | Ubiquitination | TRDELRAKALHIPFP CHHHHHHHHHCCCCC | 45.08 | 29967540 | |
| 472 | Acetylation | HIPFPVEKIINLPVV CCCCCHHHHHCCCCC | 49.47 | 19273602 | |
| 472 | N-linked_Glycosylation | HIPFPVEKIINLPVV CCCCCHHHHHCCCCC | 49.47 | 31398338 | |
| 487 | Acetylation | DFNEMMSKEQFNEAQ CHHHHCCHHHCCHHH | 37.32 | 14212485 | |
| 487 | N-linked_Glycosylation | DFNEMMSKEQFNEAQ CHHHHCCHHHCCHHH | 37.32 | 31398338 | |
| 499 | N-linked_Glycosylation | EAQLALIRDIRRRGK HHHHHHHHHHHHHCC | 33.87 | 31398338 | |
| 506 | Acetylation | RDIRRRGKNKVAAQN HHHHHHCCCHHHHHH | 52.35 | 19273602 | |
| 508 | Acetylation | IRRRGKNKVAAQNCR HHHHCCCHHHHHHHH | 36.42 | 19273602 | |
| 516 | Acetylation | VAAQNCRKRKLENIV HHHHHHHHHHHHHHH | 56.96 | 14212473 | |
| 516 | Ubiquitination | VAAQNCRKRKLENIV HHHHHHHHHHHHHHH | 56.96 | - | |
| 518 | Sumoylation | AQNCRKRKLENIVEL HHHHHHHHHHHHHHH | 64.29 | - | |
| 518 | Sumoylation | AQNCRKRKLENIVEL HHHHHHHHHHHHHHH | 64.29 | - | |
| 518 | Acetylation | AQNCRKRKLENIVEL HHHHHHHHHHHHHHH | 64.29 | 19273602 | |
| 518 | Ubiquitination | AQNCRKRKLENIVEL HHHHHHHHHHHHHHH | 64.29 | 29967540 | |
| 524 | Ubiquitination | RKLENIVELEQDLDH HHHHHHHHHHHHHHH | 42.67 | 29967540 | |
| 525 | Ubiquitination | KLENIVELEQDLDHL HHHHHHHHHHHHHHH | 5.05 | 29967540 | |
| 531 | Ubiquitination | ELEQDLDHLKDEKEK HHHHHHHHHHHHHHH | 41.92 | 29967540 | |
| 532 | Ubiquitination | LEQDLDHLKDEKEKL HHHHHHHHHHHHHHH | 8.15 | 29967540 | |
| 533 | Acetylation | EQDLDHLKDEKEKLL HHHHHHHHHHHHHHH | 61.49 | 14212483 | |
| 536 | Acetylation | LDHLKDEKEKLLKEK HHHHHHHHHHHHHHH | 70.99 | 14212459 | |
| 538 | Acetylation | HLKDEKEKLLKEKGE HHHHHHHHHHHHHCC | 70.91 | 14212479 | |
| 538 | Ubiquitination | HLKDEKEKLLKEKGE HHHHHHHHHHHHHCC | 70.91 | 29967540 | |
| 541 | Acetylation | DEKEKLLKEKGENDK HHHHHHHHHHCCCHH | 68.75 | 14212463 | |
| 543 | Acetylation | KEKLLKEKGENDKSL HHHHHHHHCCCHHHH | 70.68 | 19273602 | |
| 544 | Ubiquitination | EKLLKEKGENDKSLH HHHHHHHCCCHHHHH | 39.78 | 29967540 | |
| 548 | Ubiquitination | KEKGENDKSLHLLKK HHHCCCHHHHHHHHH | 67.51 | 29967540 | |
| 548 | Acetylation | KEKGENDKSLHLLKK HHHCCCHHHHHHHHH | 67.51 | 19273602 | |
| 549 | Phosphorylation | EKGENDKSLHLLKKQ HHCCCHHHHHHHHHH | 24.72 | 24719451 | |
| 551 | Ubiquitination | GENDKSLHLLKKQLS CCCHHHHHHHHHHHH | 35.89 | 29967540 | |
| 554 | Acetylation | DKSLHLLKKQLSTLY HHHHHHHHHHHHHHH | 44.85 | 19273602 | |
| 554 | Ubiquitination | DKSLHLLKKQLSTLY HHHHHHHHHHHHHHH | 44.85 | 29967540 | |
| 555 | Acetylation | KSLHLLKKQLSTLYL HHHHHHHHHHHHHHH | 57.34 | 19273602 | |
| 558 | Ubiquitination | HLLKKQLSTLYLEVF HHHHHHHHHHHHHHH | 17.55 | 29967540 | |
| 558 | Phosphorylation | HLLKKQLSTLYLEVF HHHHHHHHHHHHHHH | 17.55 | 19668370 | |
| 559 | Phosphorylation | LLKKQLSTLYLEVFS HHHHHHHHHHHHHHH | 28.19 | 19668370 | |
| 561 | Phosphorylation | KKQLSTLYLEVFSML HHHHHHHHHHHHHHH | 10.82 | 29759185 | |
| 569 | N-linked_Glycosylation | LEVFSMLRDEDGKPY HHHHHHHCCCCCCCC | 36.31 | 31398338 | |
| 574 | Ubiquitination | MLRDEDGKPYSPSEY HHCCCCCCCCCCHHC | 53.77 | 29967540 | |
| 574 | N-linked_Glycosylation | MLRDEDGKPYSPSEY HHCCCCCCCCCCHHC | 53.77 | 31398338 | |
| 576 | Phosphorylation | RDEDGKPYSPSEYSL CCCCCCCCCCHHCCE | 36.38 | 21690096 | |
| 577 | Phosphorylation | DEDGKPYSPSEYSLQ CCCCCCCCCHHCCEE | 30.40 | 19668370 | |
| 596 | Acetylation | GNVFLVPKSKKPDVK CCEEEEECCCCCCCC | 68.38 | 21196497 | |
| 599 | Acetylation | FLVPKSKKPDVKKN- EEEECCCCCCCCCC- | 54.24 | 21196497 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 40 | S | Phosphorylation | Kinase | PKC_GROUP | - | PhosphoELM |
| 40 | S | Phosphorylation | Kinase | PKC | - | Uniprot |
| 40 | S | Phosphorylation | Kinase | PKC-FAMILY | - | GPS |
| 40 | S | Phosphorylation | Kinase | PKCZ | Q05513 | PSP |
| 40 | S | Phosphorylation | Kinase | PKCI | P41743 | PSP |
| 344 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
| 347 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
| 374 | S | Phosphorylation | Kinase | AMPKA1 | Q13131 | PSP |
| 395 | T | Phosphorylation | Kinase | CDK5 | Q00535 | PSP |
| 408 | S | Phosphorylation | Kinase | AMPKA1 | Q13131 | PSP |
| 433 | S | Phosphorylation | Kinase | CDK5 | Q00535 | PSP |
| 433 | S | Phosphorylation | Kinase | AMPKA1 | Q13131 | PSP |
| 439 | T | Phosphorylation | Kinase | CDK5 | Q00535 | PSP |
| 576 | Y | Phosphorylation | Kinase | FYN | P06241 | PSP |
| 576 | Y | Phosphorylation | Kinase | FGR | P09769 | PSP |
| 576 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
| 576 | Y | Phosphorylation | Kinase | YES | P07947 | PSP |
| - | K | Ubiquitination | E3 ubiquitin ligase | BTRC | Q9Y297 | PMID:24658274 |
| - | K | Ubiquitination | E3 ubiquitin ligase | KEAP1 | Q14145 | PMID:14585973 |
| - | K | Ubiquitination | E3 ubiquitin ligase | RBX1 | P62877 | PMID:23274085 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NF2L2_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Acetylation-deacetylation of the transcription factor Nrf2 (nuclearfactor erythroid 2-related factor 2) regulates its transcriptionalactivity and nucleocytoplasmic localization."; Kawai Y., Garduno L., Theodore M., Yang J., Arinze I.J.; J. Biol. Chem. 286:7629-7640(2011). Cited for: ACETYLATION AT LYS-596 AND LYS-599, DEACETYLATION BY SIRT1, ANDSUBCELLULAR LOCATION. | |